<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: AbbVie and Eisai Subsidiary EA Pharma Commence Co-promotion of Fully Human Anti-TNF-a Monoclonal Antibody HUMIRA® in the Field of Gastrointestinal   Disease	</title>
	<atom:link href="https://www.worldpharmatoday.com/news/abbvie-and-eisai-subsidiary-ea-pharma-commence-co-promotion-of-fully-human-anti-tnf-a-monoclonal-antibody-humira-in-the-field-of-gastrointestinal-disease/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.worldpharmatoday.com/news/abbvie-and-eisai-subsidiary-ea-pharma-commence-co-promotion-of-fully-human-anti-tnf-a-monoclonal-antibody-humira-in-the-field-of-gastrointestinal-disease/</link>
	<description>Magazine for the C-level Pharma Executives</description>
	<lastBuildDate>Fri, 03 Jun 2016 11:36:17 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
</channel>
</rss>
